Excedrin Shortage Update: What Patients Need to Know in 2026

If you're searching for an Excedrin shortage update in 2026, here's the short answer: there is no active FDA-listed shortage of Excedrin in 2026. The shortage that concerned millions of migraine patients happened in early 2020 and was resolved by mid-year. Excedrin has been back on pharmacy shelves consistently since then.

That said, individual pharmacies can run low on specific Excedrin products — and patients who experienced the 2020 shortage are understandably cautious. Here's everything you need to know about Excedrin's availability in 2026.

What Is the Current Status of Excedrin Availability?

As of 2026, Excedrin is broadly available at major pharmacy chains (CVS, Walgreens, Rite Aid), grocery pharmacies (Kroger, Publix, Albertsons), mass retailers (Walmart, Target), and online retailers (Amazon). Multiple bottle sizes and formulations — Extra Strength, Migraine, Tension Headache, PM Headache — are in normal production by Haleon, the current brand owner.

The FDA's Drug Shortages Database does not list Excedrin or its generic equivalent (acetaminophen/aspirin/caffeine) as a current shortage. If you're unable to find Excedrin at a particular store, it is most likely a localized restocking issue rather than a supply chain problem.

What Caused the Excedrin Shortage in 2020?

On January 21, 2020, then-owner GlaxoSmithKline voluntarily halted production and distribution of Excedrin Extra Strength and Excedrin Migraine caplets and geltabs. The cause was a quality control finding: GSK's routine testing revealed "inconsistencies in how we transfer and weigh ingredients" during the manufacturing process. The company emphasized this was a precautionary measure and that there was no confirmed safety risk to consumers.

The halt affected the two most popular Excedrin products. Other formulations — including Excedrin Tension Headache and Excedrin PM Headache — remained available throughout the shortage period.

When Did Excedrin Come Back?

GSK resumed production and Excedrin Extra Strength and Migraine products returned to retailer shelves approximately July 2020 — about six months after the production halt began. Since then, no further manufacturing shutdowns have been announced by Haleon (which took over the brand from GSK in July 2022).

Was There Ever an Official Excedrin Recall?

The 2020 event was NOT a recall — it was a voluntary production halt. GSK made clear that products already on shelves were not considered unsafe and did not need to be returned.

However, there was a separate recall in December 2020: The U.S. Consumer Product Safety Commission announced a recall of approximately 400,000 bottles of Excedrin due to potential holes in the plastic container bottoms, which could allow children to access the caplets. That recall targeted specific lot numbers of packaged product and did not cause a broader supply disruption.

What Should Patients Do If They Can't Find Excedrin?

If your usual pharmacy is out of Excedrin in 2026, try these steps:

Try a generic equivalent: Store-brand Migraine Relief (250 mg acetaminophen, 250 mg aspirin, 65 mg caffeine) is bioequivalent to Excedrin Migraine and costs less.

Check nearby pharmacies: Stock varies by location. Try 2-3 pharmacies in your area.

Use medfinder: medfinder.com is a paid service that calls pharmacies near you on your behalf and reports back which ones can fill your medication request — saving you from calling multiple pharmacies yourself.

Order online: Excedrin is available on Amazon and pharmacy websites without a prescription. Same-day delivery is available from many major retailers in most metro areas.

Consider a prescription alternative: For patients with frequent or severe migraines, prescription triptans (sumatriptan, rizatriptan) may provide more reliable relief. Talk to your doctor.

Could There Be Another Excedrin Shortage in the Future?

It's impossible to fully rule out future disruptions — any manufacturer can encounter production issues or recalls. However, Excedrin's ingredients (acetaminophen, aspirin, caffeine) are all widely manufactured generic compounds with multiple suppliers, which provides inherent resilience. Generic versions are always available from numerous manufacturers even if the brand encounters issues.

For more background on what drove the 2020 shortage, see our deep dive on why Excedrin was so hard to find.